

A remifentanil/ketamine sedation in surgical cancer patients having severe Parkinson’s disease: Two case reports
Abstract
Keywords
References
Jocoy EL, André VM, Cummings DM, et al.: Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-D-aspartate currents by dopamine D1 receptor activation in striatum. Front Syst Neurosci. 2011; 5: 28.
Dyson SC, Barker RA: Cell-based therapies for Parkinson’s disease. Expert Rev Neurother. 2011; 11(6): 831-44.
Starr MS, Starr BS, Kaur S: Stimulation of basal and L-DOPA induced motor activity by glutamate antagonists in animal models of Parkinson’s disease. Neurosci Biobehay Rev. 1997; 21: 437-446.
Justin J. Wright, Peter D. Goodnight, et al.: The utility of ketamine for the preoperative management of a patient with Parkinson’s disease. Anesth Analg. 2009; 108: 980-982.
DOI: https://doi.org/10.5055/jom.2012.0106
Refbacks
- There are currently no refbacks.